You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Brimonidine Tartrate And Timolol Maleate, and what generic alternatives are available?

Brimonidine Tartrate And Timolol Maleate is a drug marketed by Alembic, Apotex, Florida, Glenmark Pharms Ltd, Sandoz, Sentiss, Somerset, and Upsher Smith Labs. and is included in eight NDAs.

The generic ingredient in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is brimonidine tartrate; timolol maleate. There are eleven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Brimonidine Tartrate And Timolol Maleate

A generic version of BRIMONIDINE TARTRATE AND TIMOLOL MALEATE was approved as brimonidine tartrate; timolol maleate by SANDOZ on April 4th, 2022.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
  • What are the global sales for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
  • What is Average Wholesale Price for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
Summary for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
US Patents:0
Applicants:8
NDAs:8
Finished Product Suppliers / Packagers: 11
Raw Ingredient (Bulk) Api Vendors: 4
Clinical Trials: 6
Patent Applications: 42
What excipients (inactive ingredients) are in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?BRIMONIDINE TARTRATE AND TIMOLOL MALEATE excipients list
DailyMed Link:BRIMONIDINE TARTRATE AND TIMOLOL MALEATE at DailyMed
Drug patent expirations by year for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Recent Clinical Trials for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AllerganPhase 3
Allergan
AllerganPhase 4

See all BRIMONIDINE TARTRATE AND TIMOLOL MALEATE clinical trials

Pharmacology for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

US Patents and Regulatory Information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 215230-001 Aug 25, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Somerset BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 216114-001 Sep 10, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glenmark Pharms Ltd BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 214987-001 May 16, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Upsher Smith Labs BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 215598-001 Dec 12, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 091442-001 Apr 20, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Florida BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 201949-001 Oct 4, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sentiss BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 091086-001 Oct 31, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.